A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
Clinical trial NCT06113471 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06113471
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2026-03-17
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.